Sort by
Body Composition Phenotypes and Functional Limitations in Older Adults: The Impact of Sarcopenia, Obesity, and Sarcopenic Obesity
Marika Murawiak
,Marta Lewandowicz-Czarnecka
,Beata Kaczmarek
,Ewa Deskur-Śmielecka
,Katarzyna Wieczorowska-Tobis
,Roma Krzymińska-Siemaszko
Background/Objectives: Sarcopenia, obesity, and sarcopenic obesity (SO) are common in older adults and may be associated with functional limitations in basic (ADL) and instrumental (IADL) activities of daily living. This study aimed to evaluate the association between body composition phenotypes and ADL/IADL limitations among older adults. Methods: A cross-sectional study included 440 community-dwelling adults aged ≥60 years (281 women, 159 men; mean age 74.7 ± 7.8 years). Sarcopenia was diagnosed according to EWGSOP2 criteria, obesity was defined as percent body fat >42% in women and >30% in men, and SO was classified based on the ESPEN/EASO recommendations. Participants without obesity or sarcopenia were categorized as ‘normal’ phenotype. Functional status was evaluated using the Katz and Lawton scales, with limitations defined as ADL ≤5 and IADL ≤26 points, respectively. Multivariate logistic regression analysis was performed to determine factors associated with ADL and IADL limitations. Results: Over half of the participants (57.1%) had abnormal body composition: 31.6% obesity, 11.4% sarcopenia, and 13.2% SO. SO was associated with a nearly threefold higher risk of ADL limitations (OR = 2.86; p = 0.003) and a 3.7-fold higher risk of IADL limitations (OR = 3.68; p < 0.001) compared to the normal phenotype. Sarcopenia was associated with IADL limitations in the unadjusted model (OR = 2.44; p = 0.010). Independent predictors of ADL and IADL limitations included reduced muscle strength, a higher number of chronic diseases, and a worse nutritional status. Conclusions SO was linked to higher risk of both ADL and IADL limitations, while sarcopenia was associated only with IADL deficits. Obesity severity may be relevant, but its impact on daily functioning in older adults requires further study.
Background/Objectives: Sarcopenia, obesity, and sarcopenic obesity (SO) are common in older adults and may be associated with functional limitations in basic (ADL) and instrumental (IADL) activities of daily living. This study aimed to evaluate the association between body composition phenotypes and ADL/IADL limitations among older adults. Methods: A cross-sectional study included 440 community-dwelling adults aged ≥60 years (281 women, 159 men; mean age 74.7 ± 7.8 years). Sarcopenia was diagnosed according to EWGSOP2 criteria, obesity was defined as percent body fat >42% in women and >30% in men, and SO was classified based on the ESPEN/EASO recommendations. Participants without obesity or sarcopenia were categorized as ‘normal’ phenotype. Functional status was evaluated using the Katz and Lawton scales, with limitations defined as ADL ≤5 and IADL ≤26 points, respectively. Multivariate logistic regression analysis was performed to determine factors associated with ADL and IADL limitations. Results: Over half of the participants (57.1%) had abnormal body composition: 31.6% obesity, 11.4% sarcopenia, and 13.2% SO. SO was associated with a nearly threefold higher risk of ADL limitations (OR = 2.86; p = 0.003) and a 3.7-fold higher risk of IADL limitations (OR = 3.68; p < 0.001) compared to the normal phenotype. Sarcopenia was associated with IADL limitations in the unadjusted model (OR = 2.44; p = 0.010). Independent predictors of ADL and IADL limitations included reduced muscle strength, a higher number of chronic diseases, and a worse nutritional status. Conclusions SO was linked to higher risk of both ADL and IADL limitations, while sarcopenia was associated only with IADL deficits. Obesity severity may be relevant, but its impact on daily functioning in older adults requires further study.
Posted: 10 December 2025
Effect of Vitamin K Supplementation on Insulin Secretion, Fibroblast Growth Factor (FGF) 19 and 20 in Post-Menopausal Women: A Randomised Controlled Trial
Eunji Kim
,Amelia E. Moore
,Renata Gorska
,Kieran Voong
,Dominic Jon Harrington
,Geeta Hampson
Introduction: We hypothesised that vitamin K (VK) may have potential effect on insulin secretion and FGF-19 and FGF 21 may modulate the vitamin K/insulin pathway. We investigated whether vitamin K1 or K2 supplementation for 18 months can affect insulin secretion and FGF19 and FGF21 production. Methods: We conducted exploratory analyses using stored samples from an 18-month randomised double-blind placebo controlled trial of VK1 (1 mg/day) or VK2 (menaquinone-4, MK4 45 mg/day)) in 105 post-menopausal women with osteoporosis (PMO) aged between 55-85 years which looked at the effect of VK supplementation on bone mineral density. In the current study, plasma insulin (primary outcome), FGF19 and FGF21 (secondary outcomes) were measured at baseline, 6 and 18 months. Results: Plasma insulin at 6 and 18 months increased significantly compared to baseline value in both treatment arms (VK1 and VK2 (MK4) ) (Median Insulin [IQR] VK1: baseline : 41.2 [29.3, 54.3] pmol/L, 6 months: 59.7 [37.8, 89.5] pmol/L p<0.001, 18 months: 54.3[43.5, 73] pmol/L (p= 0.05), VK2 (MK4) arm (Median Insulin [IQR]: baseline: 44.3[30.6, 60.9], 6 months: 63.2[43.5, 97] pmol/L p=0.011, 18 months: 54.2[40.7, 103.5] pmol/L p=0.05) in within-group analyses. No significant changes were seen in the placebo group. Circulating FGF21 tended to be higher at 6 months (p=0.045) compared to baseline following VK2 (MK4) only. Conclusions: Improving VK status in post-menopausal women may improve insulin secretion. Our data suggest that MK4’s effect on the insulin axis may be mediated, at least in part, by FGF21. Further studies are needed for confirmation.
Introduction: We hypothesised that vitamin K (VK) may have potential effect on insulin secretion and FGF-19 and FGF 21 may modulate the vitamin K/insulin pathway. We investigated whether vitamin K1 or K2 supplementation for 18 months can affect insulin secretion and FGF19 and FGF21 production. Methods: We conducted exploratory analyses using stored samples from an 18-month randomised double-blind placebo controlled trial of VK1 (1 mg/day) or VK2 (menaquinone-4, MK4 45 mg/day)) in 105 post-menopausal women with osteoporosis (PMO) aged between 55-85 years which looked at the effect of VK supplementation on bone mineral density. In the current study, plasma insulin (primary outcome), FGF19 and FGF21 (secondary outcomes) were measured at baseline, 6 and 18 months. Results: Plasma insulin at 6 and 18 months increased significantly compared to baseline value in both treatment arms (VK1 and VK2 (MK4) ) (Median Insulin [IQR] VK1: baseline : 41.2 [29.3, 54.3] pmol/L, 6 months: 59.7 [37.8, 89.5] pmol/L p<0.001, 18 months: 54.3[43.5, 73] pmol/L (p= 0.05), VK2 (MK4) arm (Median Insulin [IQR]: baseline: 44.3[30.6, 60.9], 6 months: 63.2[43.5, 97] pmol/L p=0.011, 18 months: 54.2[40.7, 103.5] pmol/L p=0.05) in within-group analyses. No significant changes were seen in the placebo group. Circulating FGF21 tended to be higher at 6 months (p=0.045) compared to baseline following VK2 (MK4) only. Conclusions: Improving VK status in post-menopausal women may improve insulin secretion. Our data suggest that MK4’s effect on the insulin axis may be mediated, at least in part, by FGF21. Further studies are needed for confirmation.
Posted: 10 December 2025
The Economy of Truth: How Resources Shape What can be Known
Arturo Tozzi
Posted: 10 December 2025
Growth of Listeria monocytogenes in Goat’s Pasteurized Milk Cheese During Maturation: Its Prediction from a Milk Model Medium
Yara Loforte
,Mariem Zanzan
,André Martinho de Almeida
,Vasco Cadavez
,Ursula Gonzales-Barron
Previous research showed that a strain of Leuconostoc mesenteroides, isolated from goat’s raw milk cheese, was effective in slowing down the growth and reducing the maximum concentration of L. monocytogenes when evaluated in a milk model; and, furthermore, that the extent of inhibition was dependent on the milk initial pH. The objectives of this study were: (1) to determine whether the growth of L. monocytogenes in goat’s pasteurized milk cheese during maturation could be approximated from growth data obtained in the milk model medium, either in monoculture or in coculture with L. mesenteroides; and if so; (2) to model a milk-to-cheese conversion factor (Cf) for L. monocytogenes growth rate. Challenge tests were conducted by inoculating L. monocytogenes in monoculture and in coculture with L. mesenteroides in goat’s pasteurized milk adjusted at initial pH levels of 5.5, 6.0 and 6.5. The process of cheesemaking went on, and cheeses were ripened at 12 ºC during 12 days. Each experimental growth curve was adjusted to a pH-driven dynamic model where the microbial maximum growth rate is a function of pH. As observed in the milk model medium, in coculture with L. mesenteroides, the optimum growth rate (μopt) of L. monocytogenes in maturing cheese was affected by the initial pH of milk: the lowest rate of 0.863 ± 0.042 day-1 was obtained at the initial pH 5.5, in comparison to 1.239 ± 0.208 and 1.038 ± 0.308 day-1 at pH 6.0 and 6.5, respectively. Regardless of the milk initial pH, L. mesenteroides did not reduce the maximum load of L. monocytogenes in maturing cheeses, as it did in the milk medium. By contrary, at the milk initial pH of 5.5, 6.0, and 6.5, L. mesenteroides was able to decrease, on average, 2.2-fold, 1.5-fold and 1.9-fold the μopt of L. monocytogenes in both milk medium and cheese, without significant differences between matrices. Following such validation in goat’s cheese, the square-root of milk-to-cheese Cf for L. monocytogenes was estimated as 0.751 (SE=0.0108), and type of culture (monoculture, coculture) was not found to affect Cf (p=0.320). In conclusion, this work validated pre-acidification of milk as an efficient strategy that, when combined with the use of a protective culture, can synergically enhance the control of L. monocytogenes in cheese.
Previous research showed that a strain of Leuconostoc mesenteroides, isolated from goat’s raw milk cheese, was effective in slowing down the growth and reducing the maximum concentration of L. monocytogenes when evaluated in a milk model; and, furthermore, that the extent of inhibition was dependent on the milk initial pH. The objectives of this study were: (1) to determine whether the growth of L. monocytogenes in goat’s pasteurized milk cheese during maturation could be approximated from growth data obtained in the milk model medium, either in monoculture or in coculture with L. mesenteroides; and if so; (2) to model a milk-to-cheese conversion factor (Cf) for L. monocytogenes growth rate. Challenge tests were conducted by inoculating L. monocytogenes in monoculture and in coculture with L. mesenteroides in goat’s pasteurized milk adjusted at initial pH levels of 5.5, 6.0 and 6.5. The process of cheesemaking went on, and cheeses were ripened at 12 ºC during 12 days. Each experimental growth curve was adjusted to a pH-driven dynamic model where the microbial maximum growth rate is a function of pH. As observed in the milk model medium, in coculture with L. mesenteroides, the optimum growth rate (μopt) of L. monocytogenes in maturing cheese was affected by the initial pH of milk: the lowest rate of 0.863 ± 0.042 day-1 was obtained at the initial pH 5.5, in comparison to 1.239 ± 0.208 and 1.038 ± 0.308 day-1 at pH 6.0 and 6.5, respectively. Regardless of the milk initial pH, L. mesenteroides did not reduce the maximum load of L. monocytogenes in maturing cheeses, as it did in the milk medium. By contrary, at the milk initial pH of 5.5, 6.0, and 6.5, L. mesenteroides was able to decrease, on average, 2.2-fold, 1.5-fold and 1.9-fold the μopt of L. monocytogenes in both milk medium and cheese, without significant differences between matrices. Following such validation in goat’s cheese, the square-root of milk-to-cheese Cf for L. monocytogenes was estimated as 0.751 (SE=0.0108), and type of culture (monoculture, coculture) was not found to affect Cf (p=0.320). In conclusion, this work validated pre-acidification of milk as an efficient strategy that, when combined with the use of a protective culture, can synergically enhance the control of L. monocytogenes in cheese.
Posted: 10 December 2025
Design and Realization of Dynamically Adjustable Multi-Pulse Real-Time Coherent Integration System
Jinrui Bi
,Lihua Sun
,Qingchao Jiang
Posted: 10 December 2025
Millimeter Wave Radar and Mixed Reality Virtual Reality System for Agility Analysis
Yung-Hoh Sheu
,Li-Wei Tai
,Sheng-K Wu
,Tz-Yun Chen
,Li-Chun Chang
Posted: 10 December 2025
FESW-UNet : A Dual-Domain Attention Network for Sorghum Aphid Segmentation
Caijian Hua
,Fangjun Ren
Posted: 10 December 2025
Impact of Dividend Distribution and Its Risk on Stock Value an Empirical Study in the Saudi Stock Market
Osama Azmi Sallam
,Lobna Ahmed Mohamed
,Amira Hamadi Gaddour
This study empirically investigates the impact of both the level and risk of cash dividend distributions on the stock value of companies listed on the Saudi Stock Exchange (Tadawul). Utilizing a proportional stratified random sample of 120 companies across 21 sectors over the period 2020-2024, the research employs third-degree polynomial regression models to analyze complex, non-linear relationships. The findings reveal a significant cubic relationship, identifying an optimal dividend per share of 5.91 SAR that maximizes stock price. Furthermore, dividend volatility (risk) exhibits an inverted S-shaped relationship with price, with an optimal standard deviation of 5.04 SAR, indicating that the market rewards a dynamically stable payout policy. The study also uncovers strong sectoral effects, with Telecommunication, Health Care, and Energy sectors commanding significant valuation premiums, while Real Estate and Financial Services trade at discounts. The results robustly confirm that both dividend level and stability are critical, sector-dependent determinants of firm value in the Saudi market. These insights provide valuable guidance for corporate dividend strategy, investment decision-making, and policy formulation within the context of Saudi Vision 2030.
This study empirically investigates the impact of both the level and risk of cash dividend distributions on the stock value of companies listed on the Saudi Stock Exchange (Tadawul). Utilizing a proportional stratified random sample of 120 companies across 21 sectors over the period 2020-2024, the research employs third-degree polynomial regression models to analyze complex, non-linear relationships. The findings reveal a significant cubic relationship, identifying an optimal dividend per share of 5.91 SAR that maximizes stock price. Furthermore, dividend volatility (risk) exhibits an inverted S-shaped relationship with price, with an optimal standard deviation of 5.04 SAR, indicating that the market rewards a dynamically stable payout policy. The study also uncovers strong sectoral effects, with Telecommunication, Health Care, and Energy sectors commanding significant valuation premiums, while Real Estate and Financial Services trade at discounts. The results robustly confirm that both dividend level and stability are critical, sector-dependent determinants of firm value in the Saudi market. These insights provide valuable guidance for corporate dividend strategy, investment decision-making, and policy formulation within the context of Saudi Vision 2030.
Posted: 10 December 2025
Emergence and Evolution of Triple Reassortant Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025
Estefania Benedetti
,Maria Carolina Artuso
,Alexander M. P. Byrne
,Maria de Belen Garibotto
,Martín Avaro
,Luana Erica Piccini
,Ariana Chamorro
,Marcelo Sciorra
,Vanina Daniela Marchione
,Mara Laura Russo
+5 authors
Posted: 10 December 2025
Antifungal Potential of Diaporthe sp. Endophytes from Antillean Avocado Against Fusarium spp.: From Organic Extracts to In Silico Chitin Synthase Inhibition
Angie T. Robayo-Medina
,Katheryn Michell Camargo-Jimenez
,Felipe Victoria-Muñoz
,Wilman Delgado-Avila
,Luis Enrique Cuca
,Mónica Ávila-Murillo
Posted: 10 December 2025
The Meaning of “Big Bang”
Emilio Elizalde
Posted: 10 December 2025
Title Early Identification of Tick Species from Eschar Lesions: A Potential Strategy for Pre-Symptomatic Intervention in Tick-Borne Diseases
Makoto Kondo
,Koji Habe
,Keiichi Yamanaka
In endemic regions where simultaneous larval tick bites are common, early species-level information obtained from eschar lesions can meaningfully change pre-symptomatic triage. We report a 78-year-old woman found after ~24 hours of wandering with multiple clustered eschars on the legs and attached ticks on the trunk. PCR and Sanger sequencing of two removed ticks and ten representative eschars identified Amblyomma testudinarium in all samples. Because A. testudinarium is a known vector of severe fever with thrombocytopenia syndrome (SFTS) virus but not of Rickettsia japonica, we deprioritized Japanese spotted fever and focused targeted monitoring on early SFTS features. The patient remained asymptomatic and was transferred to long-term care. This case illustrates that, particularly in high-incidence settings with numerous bite sites, selective PCR of representative eschars provides a rapid and resource-sparing means to infer vector species and tailor risk assessment before symptom onset. Emphasizing eschar-based species identification in endemic areas can concentrate testing where pretest probability is highest, streamline surveillance, and support shared decision-making in frontline practice.
In endemic regions where simultaneous larval tick bites are common, early species-level information obtained from eschar lesions can meaningfully change pre-symptomatic triage. We report a 78-year-old woman found after ~24 hours of wandering with multiple clustered eschars on the legs and attached ticks on the trunk. PCR and Sanger sequencing of two removed ticks and ten representative eschars identified Amblyomma testudinarium in all samples. Because A. testudinarium is a known vector of severe fever with thrombocytopenia syndrome (SFTS) virus but not of Rickettsia japonica, we deprioritized Japanese spotted fever and focused targeted monitoring on early SFTS features. The patient remained asymptomatic and was transferred to long-term care. This case illustrates that, particularly in high-incidence settings with numerous bite sites, selective PCR of representative eschars provides a rapid and resource-sparing means to infer vector species and tailor risk assessment before symptom onset. Emphasizing eschar-based species identification in endemic areas can concentrate testing where pretest probability is highest, streamline surveillance, and support shared decision-making in frontline practice.
Posted: 10 December 2025
Predictive Biomarkers for Asymptomatic Adults: Opportunities, Risks, and Guidance for General Practice
Christian J. Wiedermann
,Adolf Engl
,Giuliano Piccoliori
,Doris Hager von Strobele-Prainsack
Background/Objectives: Biomarker-based prevention is rapidly expanding, driven by advances in molecular diagnostics, genetic profiling, and commercial direct-to-consumer (DTC) testing. General practitioners (GPs) increasingly encounter biomarker results of uncertain relevance, often introduced outside the guideline frameworks. This creates new challenges in interpretation, communication, and equitable resource use in primary care. Methods: This narrative review synthesizes evidence from population-based studies, guideline frameworks, consensus statements, and communication research to evaluate the predictive value, limitations, and real-world implications of biomarkers in asymptomatic adults. Attention is given to polygenic risk scores, DTC genetic tests, neurodegenerative and cardiovascular biomarkers, and emerging multi-omics and aging markers. Results: Several biomarkers, including high-sensitivity cardiac troponins, N-terminal pro–B-type natriuretic peptide, lipoprotein(a), coronary artery calcium scoring, and plasma p-tau species, showed robust predictive validity. However, many widely marketed biomarkers lack evidence of clinical utility, offer limited actionable benefits, or perform poorly in primary care populations. Unintended consequences, such as overdiagnosis, false positives, psychological distress, diagnostic cascades, and widening inequities, are well documented. Patients often misinterpret unvalidated biomarker results, whereas DTC testing amplifies demand without providing adequate counseling or follow-up. Conclusions: Only a minority of biomarkers currently meet the thresholds of analytical validity, clinical validity, and clinical utility required for preventive use in general practices. GPs play a critical role in contextualizing biomarker results, guiding shared decision-making, and mitigating potential harm. The responsible integration of biomarkers into preventive medicine requires clear communication, strong ethical safeguards, robust evidence, and system-level support for equitable, patient-centered care.
Background/Objectives: Biomarker-based prevention is rapidly expanding, driven by advances in molecular diagnostics, genetic profiling, and commercial direct-to-consumer (DTC) testing. General practitioners (GPs) increasingly encounter biomarker results of uncertain relevance, often introduced outside the guideline frameworks. This creates new challenges in interpretation, communication, and equitable resource use in primary care. Methods: This narrative review synthesizes evidence from population-based studies, guideline frameworks, consensus statements, and communication research to evaluate the predictive value, limitations, and real-world implications of biomarkers in asymptomatic adults. Attention is given to polygenic risk scores, DTC genetic tests, neurodegenerative and cardiovascular biomarkers, and emerging multi-omics and aging markers. Results: Several biomarkers, including high-sensitivity cardiac troponins, N-terminal pro–B-type natriuretic peptide, lipoprotein(a), coronary artery calcium scoring, and plasma p-tau species, showed robust predictive validity. However, many widely marketed biomarkers lack evidence of clinical utility, offer limited actionable benefits, or perform poorly in primary care populations. Unintended consequences, such as overdiagnosis, false positives, psychological distress, diagnostic cascades, and widening inequities, are well documented. Patients often misinterpret unvalidated biomarker results, whereas DTC testing amplifies demand without providing adequate counseling or follow-up. Conclusions: Only a minority of biomarkers currently meet the thresholds of analytical validity, clinical validity, and clinical utility required for preventive use in general practices. GPs play a critical role in contextualizing biomarker results, guiding shared decision-making, and mitigating potential harm. The responsible integration of biomarkers into preventive medicine requires clear communication, strong ethical safeguards, robust evidence, and system-level support for equitable, patient-centered care.
Posted: 10 December 2025
Nonparametric Functional Least Absolute Relative Error Regression: Application to Econophysics
Ali Laksaci
,Ibrahim M. Almanjahi
,Mustapha Rachdi
Posted: 10 December 2025
Food Adulteration Problem: A Situation Analysis and Way forward
Raya Adiba
Posted: 10 December 2025
Urban Green Space Per Capita for Sustainable and Equitable Urban Planning: A Systematic Review and Bibliometric Analysis
Yaseen N. Hassan
,Sándor Jombach
Posted: 10 December 2025
The Sextuple Helix Innovation Model: Positioning Generative AI as an Epistemic Agent in Creative and Sustainable Knowledge Economies
Lutz Peschke
Posted: 10 December 2025
Prognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Trans-Planted Patients
Giulianno Molina de Melo
,Murilo Catafesta das Neves
,Rafael Dias Romero
,Marcello Rosano
,Rodrigo Tadashi Martines
,Roberto Massao Takimoto
,Barbara Greggio
,Marcel das Neves Palumbo
,Fabio Brodskyn
,Arthur Paredes Gatti
+6 authors
Posted: 10 December 2025
The Perspectives of Entrepreneurship in Enhancing Sustainable Development in South Africa
Andrew Enaifoghe
,Trisha Ramsuraj
Posted: 10 December 2025
Climate-Driven Shifts in Rainy and Dry Season Timing in the Tropical Andes Using Harmonic Analysis
Sheila Serrano-Vincenti
,Jonathan González-Chuqui
,Mariana Luna-Cadena
,León Escobar
Posted: 10 December 2025
of 5,313